中国医药导报2024,Vol.21Issue(3) :40-45.DOI:10.20047/j.issn1673-7210.2024.03.07

68Ga-PSMA-11-PET/CT在诊断前列腺癌淋巴结转移中的应用进展

Application progress of 68Ga-PSMA-11-PET/CT in the diagnosis of lymph node metastasis in prostate cancer

郑杨煌 杨嘉鑫 施鸿金 王海峰 左毅刚 王剑松 张劲松
中国医药导报2024,Vol.21Issue(3) :40-45.DOI:10.20047/j.issn1673-7210.2024.03.07

68Ga-PSMA-11-PET/CT在诊断前列腺癌淋巴结转移中的应用进展

Application progress of 68Ga-PSMA-11-PET/CT in the diagnosis of lymph node metastasis in prostate cancer

郑杨煌 1杨嘉鑫 1施鸿金 1王海峰 1左毅刚 1王剑松 1张劲松1
扫码查看

作者信息

  • 1. 昆明医科大学第二附属医院泌尿外科 云南泌尿研究所,云南昆明 650101
  • 折叠

摘要

前列腺癌淋巴结转移常与预后差、生存周期短等结局相关.CT、MRI在诊断前列腺癌淋巴结转移方面准确率低.镓-68标记前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描这项技术的引入,改善了前列腺癌的诊断水平和治疗方案.本文就该项技术对比常规影像学和其他示踪剂在前列腺癌和前列腺癌淋巴结转移的诊断准确率、识别生化复发病灶、改善挽救性放射治疗方案及非淋巴结转移显像点作一综述.

Abstract

Lymph node metastasis of prostate cancer is frequently associated with a poor prognosis and a short survival cycle.CT and MRI have low accuracy in identifying prostate cancer lymph node metastases.The introduction of Gallium-68 labeled prostate-specific membrane antigen positron emission tomography/computed tomography has improved the diagnosis and treatment of prostate cancer,it has improved the diagnosis and treatment of prostate cancer.In this paper,the accuracy of this technique compared with conventional imaging and other tracers in the diagnosis of prostate cancer and lymph node metastasis,identification of biochemical recurrent foci,improvement of salvage radiation therapy and non-lymph node metastasis imaging sites are reviewed.

关键词

前列腺癌/前列腺特异性膜抗原/淋巴结转移/镓-68/正电子发射断层扫描

Key words

Prostate cancer/Prostate specific membrane antigen/Lymph node metastasis/Gallium-68/Positron emission tomography

引用本文复制引用

基金项目

国家自然科学基金资助项目(81972395)

出版年

2024
中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
参考文献量42
段落导航相关论文